HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Truvada (Tenofovir/FTC)

The Basics | News | Research

Show Archived (Historical) Articles

Brand Name:	Truvada
Generic Name:	Emtricitabine + tenofovir disoproxil fumarate, FTC/TDF
Adult Single Dose:	One tablet containing 200 mg FTC and 300 mg TDF (once a day)
Food & Liquid Restrictions:	None
Drug Class:	NRTI

From The Body's "Ask the Experts" Forums

My HIV diagnosis has just been confirmed, although I think it's likely my infection dates back a number of years. My CD4 count is 94 and I'm about to start treatment, even though I've been told that I don't have any "real symptoms" yet. Does this sound OK -- and is Truvada a good medication to start with?
Is it better to take Sustiva (Stocrin, efavirenz) and Truvada (tenofovir/FTC) as two separate pills, or take Atripla (efavirenz/tenofovir/FTC), which combines these two HIV meds in one pill?
I've been taking Viramune (nevirapine) and Truvada since 2004. Recently I've started taking digestive enzymes and other dietary supplements to help with some gas and bloating problems. Can the enzymes and supplements I'm taking interact with my HIV meds?

» More questions

The Basics

An Overview of Truvada (Tenofovir/FTC) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
FAQs About Truvada (Tenofovir/FTC) From The Body's "Ask the Experts" Forums (Regularly Updated)
From The Body's "Ask the Experts" Forums
Patient Assistance Programs (Regularly Updated)
Having problems paying for Truvada? Visit Gilead's patient assistance program page.
From Gilead Sciences, Inc.
Truvada (Tenofovir + Emtricitabine) (August 22, 2009)
To read PDF, click here
From AIDS InfoNet
Truvada (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Patient Information About Truvada (Tenofovir/FTC) (PDF) (November 2008)
From Gilead Sciences, Inc.
Truvada (Viread + Emtriva) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs

News

Gilead's Fixed-Dose Combination of Truvada + Efavirenz Not Yet Bioequivalent to Drugs Alone (August 10, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration

Research

Serious Non-AIDS Health Problems (Especially Heart Problems) Appear Less Likely With Truvada Than Epzicom, But Low Bone Mineral Density Is More Likely, Switch Study Finds (October 20, 2009)
In Clinical Infectious Diseases
Topical PrEP Comparison: Tenofovir Alone May Be as Effective as Tenofovir/FTC, Study Finds (February 9, 2009)
Walid Heneine, Ph.D., explains the results of a study in macaques which found that a topical gel offered complete protection against SIV infection -- regardless of whether that gel contained tenofovir alone or tenofovir in combination with emtricitabine.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Switching From Zidovudine/Lamivudine to Tenofovir/Emtricitabine: Results of an Uncontrolled Cohort (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection
HIV JournalView: Tenofovir + Emtricitabine + Efavirenz vs. Zidovudine/Lamivudine + Efavirenz (February/March 2006)
An important study by Joel Gallant et al demonstrates the advantage of tenofovir + FTC in first-line therapy.
From The Body PRO
Data Supports Bioequivalence for Once-Daily, Single-Pill, Fixed-Dose Combination of Sustiva and Truvada, Drug Companies Announce (January 9, 2006)
Filing of a new drug application is expected in the second quarter of 2006.
To read PDF, click here
From Bristol-Myers Squibb Company and Gilead Sciences, Inc.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.